Literature DB >> 19697646

Masseter tenomyositis.

John S DuPont1, Christopher E Brown.   

Abstract

The masseter muscle is an integral part of the oral facial complex and one of the muscles of mastication. It functions with the other masticatory muscles in moving and posturing the mandible and in verbalizing, eating and swallowing. When a patient has temporomandibular dysfunction (TMD) or a myogenic disorder, the integrity of the masseter muscle can be compromised resulting in pain, malfunction, inflammation and/or swelling. A careful evaluation of the masseter muscles is necessary in facial pain patients since the pain can originate from a distant site and be referred to this area. One of the little known disorders involving the masseter and its tendinous origin is tenomyositis, in which an inflammation of the muscle and its tendon occurs. In this retrospective study, the charts of 114 consecutive patients (N = 114) were evaluated to determine the prevalence of this disorder and the reported etiology.

Entities:  

Mesh:

Year:  2009        PMID: 19697646     DOI: 10.1179/crn.2009.027

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  3 in total

1.  Infusion of Gabrα6 siRNA into the trigeminal ganglia increased the myogenic orofacial nociceptive response of ovariectomized rats treated with 17β-estradiol.

Authors:  P R Kramer; L L Bellinger
Journal:  Neuroscience       Date:  2014-08-12       Impact factor: 3.590

2.  Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain.

Authors:  Wei Guo; Hu Wang; Shiping Zou; Feng Wei; Ronald Dubner; Ke Ren
Journal:  Mol Pain       Date:  2010-07-15       Impact factor: 3.395

3.  Attenuation of myogenic orofacial nociception and mechanical hypersensitivity by viral mediated enkephalin overproduction in male and female rats.

Authors:  Phillip R Kramer; Mikhail Umorin; Larry L Bellinger
Journal:  BMC Neurol       Date:  2015-03-15       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.